kras mutation and glutathion glynac Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Targeting KRAS: from metabolic regulation
Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges PMC Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link
Pay in 4 interest-free payments of $7.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





